MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, INTI has $2,511,307 in assets. $3,803,219 in debts. $2,375,493 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
319.31%
Quick Ratio
319.31%
Cash Ratio
309.98%
Debt to Asset Ratio
151.44%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other asset...
    • Operating lease right-of-use ass...
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Deferred revenue
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
2,375,493
Prepaid expenses and other assets
71,507
Total current assets
2,447,000
Operating lease right-of-use assets
64,307
Total assets
2,511,307
Accounts payable
51,521
Accrued expenses and other liabilities
690,085
Current portion of operating lease obligations
24,724
Total current liabilities
766,330
Deferred revenue
3,000,000
Operating lease obligations, less current portion
36,889
Total liabilities
3,803,219
Common stock, 0.0001 par value 500,000,000 shares authorized 172,573,545 and 172,323,545 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively
17,257
Additional paid-in capital
54,110,425
Accumulated deficit
-55,419,594
Total stockholders (deficit) equity
-1,291,912
Total liabilities and stockholders (deficit) equity
2,511,307
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$2,375,493 Prepaid expenses andother assets$71,507 Total current assets$2,447,000 Operating leaseright-of-use assets$64,307 Total assets$2,511,307 Accumulated deficit-$55,419,594 Total liabilities andstockholders (deficit)...$2,511,307 Total stockholders(deficit) equity-$1,291,912 Additional paid-in capital$54,110,425 Common stock, 0.0001par value...$17,257 Total liabilities$3,803,219 Deferred revenue$3,000,000 Total currentliabilities$766,330 Operating leaseobligations, less current...$36,889 Accrued expenses andother liabilities$690,085 Accounts payable$51,521 Current portion ofoperating lease...$24,724

Inhibitor Therapeutics, Inc. (INTI)

Inhibitor Therapeutics, Inc. (INTI)